Daily News for Neuros, Nurses & Savvy MSers: 208,152 Viewers, 8,368 Stories & Studies
Click Here For My Videos, Advice, Tips, Studies and Trials.
Timothy L. Vollmer, MD
Department of Neurology
University of Colorado Health Sciences Center Professor

Co-Director of the RMMSC at Anschutz Medical Center

Medical Director-Rocky Mountain MS Center
Click here to read my columns
Brian R. Apatoff, MD, PhD
Multiple Sclerosis Institute
Center for Neurological Disorders

Associate Professor Neurology and Neuroscience,

Weill Medical College of Cornell University

Clinical Attending in Neurology,
New York-Presbyterian Hospital
You'll get FREE Breaking News Alerts on new MS treatments as they are approved

HERE'S A FEW OF OUR 6000+ Facebook & MySpace FRIENDS
Timothy L. Vollmer M.D.
Department of Neurology
University of Colorado Health Sciences Center
Co-Director of the RMMSC at Anschutz Medical Center
Medical Director-Rocky Mountain MS Center

Click to view 1280 MS Walk photos!

"MS Can Not
Rob You of Joy"
"I'm an Mom has MS and we have a message for everyone."
- Jennifer Hartmark-Hill MD
Beverly Dean

"I've had MS for 2 years...this is the most important advice you'll ever hear."
"This is how I give myself a painless injection."
Heather Johnson

"A helpful tip for newly diagnosed MS patients."
"Important advice on choosing MS medication "
Joyce Moore

This page is powered by Blogger. Isn't yours?



Is This Drug The Answer To Multiple Sclerosis?

Multiple Sclerosis is a progressive neurological disease affecting more than 2.3 million people worldwide. National Multiple Sclerosis Society defines it as an unpredictable and often disabling disease of the central nervous system that disrupts the communication pathway within the brain and between the body and the brain.

However, based on a new study published in the journal, "Annals of Clinical and Translational Neurology", researchers were able to find a way to reduce nerve cell damage hence reversing the effects of MS to the body. Scientists at the Centre for Addiction and Mental Health (CAMH) have discovered a promising new approach in multiple sclerosis (MS) treatment. They were able to identify an unknown change in the spinal cord that is linked to MS. Subsequently, they were able to reverse the change to reduce nerve damage.

This research could be the answer to the long-awaited cure for MS and could lead to the development of new types of drugs to treat it. Dr. Fang Liu, Senior Scientist in CAMH's Campbell Family Mental Health Research Institute and Professor in the Department of Psychiatry, University of Toronto has led the study.

Currently, the exact cause and etiology of the disease is still unclear. However, theories pointed out that it may be caused by an autoimmune response that leads to inflammation in the brain and spinal cord. Inflammation may lead to the destruction of a fatty acid called myelin. Myelin is responsible in the protection of nerve fibers from damage. When this happens, nerve fibers, nerve cells and even oligodendrocytes (produces myelin) are damaged.

Hence, the communication pathway from and to the brain becomes disrupted. As a result, patients with the condition experience a wide range of symptoms including fatigue, muscle weakness, pain, coordination problems, impaired balance, visual problems and tremors.
In the study, they analyzed and examined spinal cord tissues from MS patients and animals who died of the disease. They were able to identify an alteration in the spinal cord that involves a protein or peptide that binds to a specific cell receptor associated with glutamate, a neurotransmitter in the body.

The researchers created a new peptide, which is a tiny protein, to try and disrupt the change in their animal models with MS. Dr. Liu said as reported by Medical News Today, "We found that our peptide disrupted this linkage, and led to major improvements in neurological functioning."

The peptide had a positive impact on nerve cell damage and even reduced neuron death. The protective coating of neurons called myelin was saved from damage. Also, oligodendrocytes damage were also reduced.

Dr. Liu points out that even though many drugs that target glutamate receptors affect with nerve cell signaling in the brain, the newly created peptide do not have this effect and did not suppress the immune system.

Story Source: The above story is based on materials provided by YOUHEALTHMAG
Note: Materials may be edited for content and length

Go to Newer News Go to Older News